US OptionsDetailed Quotes
SGHT241220C5000
- 0.70
- 0.000.00%
15min DelayClose Nov 25 15:55 ET
0.00High0.00Low
0.70Open0.70Pre Close0 Volume1 Open Interest5.00Strike Price0.00Turnover248.77%IV43.22%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type0.4902Delta0.1549Gamma5.69Leverage Ratio-0.0212Theta0.0008Rho2.79Eff Leverage0.0041Vega
Sight Sciences Stock Discussion
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial
Sight Sciences (Nasdaq: SGHT) announced the publication of a new study in Clinical Ophthalmology, demonstrating the efficacy of TearCaretreatment for dry eye disease (DED). The study, titled 'Impact of TearCare on Reading Speed in Patients with Dry Eye Disease,' revealed significant improvements in various metr...
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis
Sight Sciences announced the publication of twelve-month results from the SAHARA trial, showing clinically meaningful improvements in dry eye disease for patients who switched from Restasis to the TearCare treatment. Phase 2 of the trial included 163 patients who had used Rest...
NEWS
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
Sight Sciences, Inc. (Nasdaq: SGHT) announces results of a large-scale MIGS study comparing three leading technologies in glaucoma patients. OMNI technology shows significant IOP and...
In the realm of ophthalmology, groundbreaking advancements are not just welcomed; they are necessary. As we navigate through the complexities of eye diseases, companies like Sight Sciences are leading the charge with innovative solutions that promise not only relief but also a renewed hope for millions globally. Rec...
Gapping up
$Apple (AAPL.US)$ stock rose 0.2% ahead of the iPhone maker's latest hardware update in California later in the session, which is expected to see the launch of the iPhone 15.
$Boeing (BA.US)$ stock rose 0.1% after SMBC Aviation Capital, the world's second largest aircraft leasing firm, said it had concluded an order for 25 Boeing 737 MAX aircraft in a deal worth more than $3.7 billion a...
No comment yet